Source 1primary paper2025MED
Toolkit/enzyme-linked immunosorbent assay
enzyme-linked immunosorbent assay
Also known as: ELISA
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Classical immunoassays such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), and single molecule array (SIMOA) remain central to fluid based detection, offering high sensitivity and clinical validation.
Usefulness & Problems
Why this is useful
ELISA is presented as a classical immunoassay used for fluid-based detection of p-Tau. The review describes it as central to current detection workflows.; fluid-based detection of hyperphosphorylated Tau
Source:
ELISA is presented as a classical immunoassay used for fluid-based detection of p-Tau. The review describes it as central to current detection workflows.
Source:
fluid-based detection of hyperphosphorylated Tau
Problem solved
It supports sensitive and clinically validated detection of p-Tau for diagnosis and monitoring.; provides clinically validated p-Tau detection in fluids
Source:
It supports sensitive and clinically validated detection of p-Tau for diagnosis and monitoring.
Source:
provides clinically validated p-Tau detection in fluids
Problem links
provides clinically validated p-Tau detection in fluids
LiteratureIt supports sensitive and clinically validated detection of p-Tau for diagnosis and monitoring.
Source:
It supports sensitive and clinically validated detection of p-Tau for diagnosis and monitoring.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The abstract supports that ELISA is used as an immunoassay in fluid samples, but does not specify reagents or instrumentation.; requires immunoassay format for fluid-based detection
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
ELISA, CLEIA, and SIMOA remain central to fluid-based p-Tau detection and offer high sensitivity and clinical validation.
Approval Evidence
1 source1 linked approval claimfirst-pass slug enzyme-linked-immunosorbent-assay
Classical immunoassays such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), and single molecule array (SIMOA) remain central to fluid based detection, offering high sensitivity and clinical validation.
Source:
assay utilitysupports
ELISA, CLEIA, and SIMOA remain central to fluid-based p-Tau detection and offer high sensitivity and clinical validation.
Source:
Comparisons
Source-stated alternatives
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Source-backed strengths
high sensitivity; clinical validation
Source:
high sensitivity
Source:
clinical validation
Compared with biosensors
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Compared with biosensors for active Rho detection
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Compared with chemiluminescent enzyme immunoassay
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Compared with fluorescent protein based reporters and biosensors
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Compared with genetically engineered biosensors
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Compared with single molecule array
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract contrasts ELISA with CLEIA, SIMOA, and newer electrochemical, optical, and nanostructured biosensors.
Ranked Citations
- 1.